Education
About Us
Working with TipRanks
Follow Us
Akoya Biosciences (AKYA)
NASDAQ:AKYA
Total Valuation
Akoya Biosciences has a market cap or net worth of $60.85M. The enterprise value is $183.67M.
Market Cap$60.85M
Enterprise Value$183.67M
Share Statistics
Akoya Biosciences has 49,875,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,875,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akoya Biosciences’s return on equity (ROE) is -7.29 and return on invested capital (ROIC) is -47.40%.
Return on Equity (ROE)-7.29
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-47.40%
Return on Capital Employed (ROCE)-0.49
Revenue Per Employee398.40K
Profits Per Employee-270.07K
Employee Count205
Asset Turnover0.65
Inventory Turnover1.39
Valuation Ratios
The current PE Ratio of Akoya Biosciences is -2.04. Akoya Biosciences’s PEG ratio is 0.09.
PE Ratio-2.04
PS Ratio0.00
PB Ratio14.90
Price to Fair Value14.90
Price to FCF-2.43
Price to Operating Cash Flow-2.57
PEG Ratio0.09
Income Statement
In the last 12 months, Akoya Biosciences had revenue of 81.67M and earned -55.37M in profits. Earnings per share was -1.12.
Revenue81.67M
Gross Profit47.88M
Operating Income-46.73M
Pretax Income-55.22M
Net Income-55.37M
EBITDA-37.14M
Earnings Per Share (EPS)-1.12
Cash Flow
In the last 12 months, operating cash flow was -44.10M and capital expenditures -2.46M, giving a free cash flow of -46.56M billion.
Operating Cash Flow-44.10M
Free Cash Flow-46.56M
Free Cash Flow per Share-0.93
Dividends & Yields
Akoya Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.64
52-Week Price Change-70.39%
50-Day Moving Average1.43
200-Day Moving Average2.30
Relative Strength Index (RSI)43.76
Average Volume (3m)152.65K
Important Dates
Akoya Biosciences upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 17, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Akoya Biosciences as a current ratio of 2.61, with Debt / Equity ratio of 104.86%
Current Ratio2.61
Quick Ratio1.78
Debt to Market Cap0.07
Net Debt to EBITDA0.10
Interest Coverage Ratio-4.48
Taxes
In the past 12 months, Akoya Biosciences has paid 146.00K in taxes.
Income Tax146.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Akoya Biosciences EV to EBITDA ratio is -2.94, with an EV/FCF ratio of -2.35.
EV to Sales1.34
EV to EBITDA-2.94
EV to Free Cash Flow-2.35
EV to Operating Cash Flow-2.48
Balance Sheet
Akoya Biosciences has $35.04M in cash and marketable securities with $7.96M in debt, giving a net cash position of -$27.08M billion.
Cash & Marketable Securities$35.04M
Total Debt$7.96M
Net Cash-$27.08M
Net Cash Per Share-$0.54
Tangible Book Value Per Share-$0.51
Margins
Gross margin is 58.62%, with operating margin of -57.22%, and net profit margin of -67.79%.
Gross Margin58.62%
Operating Margin-57.22%
Pretax Margin-67.61%
Net Profit Margin-67.79%
EBITDA Margin-45.47%
EBIT Margin-54.84%
Analyst Forecast
The average price target for Akoya Biosciences is $1.75, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.75
Price Target Upside43.44% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast-15.48%
EPS Growth Forecast24.53%